Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer

Volume: 47, Issue: 6, Pages: 261 - 279
Published: Apr 28, 2021
Abstract
Non-small lung (NSCLC) is the deadliest cancer, with survival measured in months. Earlier diagnosis using a robust biomarker would likely improve survival. This study aims to determine whether blood levels of the extracellular sulfatases (SULF1 and SULF2) and their bio-activity can serve as novel biomarkers for NSCLC early detection.Using human plasma specimens from NSCLC patients, nonmalignant COPD patients, and healthy individuals, we...
Paper Details
Title
Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer
Published Date
Apr 28, 2021
Volume
47
Issue
6
Pages
261 - 279
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.